Non-canonical actions of Nogo-A and its receptors

Biochemical Pharmacology

Volumn 100, Issue , 2015, Pages 28-39

  Seiler, Stefanie ^a,b   Di Santo, Stefano ^a   Widmer, Hans Rudolf ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cell signaling; Distribution; Neurodegenerative diseases; Nogo A; Nogo receptor; Regenerative medicine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; GAMMA INTERFERON; GROWTH FACTOR; MESSENGER RNA; NEUROTROPHIC FACTOR; PROTEIN NOGO A; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GROWTH INHIBITOR; MYELIN PROTEIN; PROTEIN NOGO;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAIN DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL MATURATION; CEREBROVASCULAR ACCIDENT; EAR; EPILEPSY; EYE; GLAUCOMA; GLIOMA; HUMAN; IMMUNOREGULATION; INNER EAR; LEARNING; MACROPHAGE ACTIVATION; MEMORY; MEMORY DISORDER; MICROGLIA; MULTIPLE SCLEROSIS; MYELINATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA GANGLION CELL; SCHIZOPHRENIA; ANIMAL; BRAIN; METABOLISM; MYELIN SHEATH; NERVE CELL; NEURITE; PATHOLOGY;

ANIMALS; BRAIN; GLIOMA; GPI-LINKED PROTEINS; GROWTH INHIBITORS; HUMANS; MULTIPLE SCLEROSIS; MYELIN PROTEINS; MYELIN SHEATH; NEURITES; NEURONS;

EID: 84941248806     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.08.113     Document Type: Note

References (130)

1. M.E. Schwab, and P. Caroni Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro J. Neurosci. 8 1988 2381 2393
2. D.A. Morgenstern, R.A. Asher, and J.W. Fawcett Chondroitin sulphate proteoglycans in the CNS injury response Prog. Brain Res. 137 2002 313 332
3. M. Domeniconi, Z. Cao, T. Spencer, R. Sivasankaran, K. Wang, E. Nikulina, and et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth Neuron 35 2002 283 290
4. M.S. Chen, A.B. Huber, M.E. van der Haar, M. Frank, L. Schnell, A.A. Spillmann, and et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 Nature 403 2000 434 439
5. M. Simonen, V. Pedersen, O. Weinmann, L. Schnell, A. Buss, B. Ledermann, and et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury Neuron 38 2003 201 211
6. T. GrandPre, F. Nakamura, T. Vartanian, and S.M. Strittmatter Identification of the Nogo inhibitor of axon regeneration as a reticulon protein Nature 403 2000 439 444
7. J.M. Schwab, S.K. Tuli, and V. Failli The Nogo receptor complex: confining molecules to molecular mechanisms Trends Mol. Med. 12 2006 293 297
8. N. Saha, M. Kolev, and D.B. Nikolov Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface Neurosci. Res. 87 2014 1 7
9. S. Ramasamy, F. Yu, Y. Hong Yu, H. Srivats, G.S. Dawe, and S. Ahmed NogoR1 and PirB signaling stimulates neural stem cell survival and proliferation Stem Cells 32 2014 1636 1648
10. A.B. Huber, O. Weinmann, C. Brosamle, T. Oertle, and M.E. Schwab Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions J. Neurosci. 22 2002 3553 3567
11. A. Buss, B. Sellhaus, A. Wolmsley, J. Noth, M.E. Schwab, and G.A. Brook Expression pattern of NOGO-A protein in the human nervous system Acta Neuropathol. 110 2005 113 119
12. A. Kempf, and M.E. Schwab Nogo-A represses anatomical and synaptic plasticity in the central nervous system Physiology 28 2013 151 163
13. J.Y. Huang, Y.X. Wang, W.L. Gu, S.L. Fu, Y. Li, L.D. Huang, and et al. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells Brain Res. 1437 2012 1 15
14. V. Pernet, S. Joly, F. Christ, L. Dimou, and M.E. Schwab Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation J. Neurosci. 28 2008 7435 7444
15. D. Bourikas, A. Mir, and A.R. Walmsley LINGO-1-mediated inhibition of oligodendrocyte differentiation does not require the leucine-rich repeats and is reversed by p75(NTR) antagonists Mol. Cell. Neurosci. 45 2010 363 369
16. S. Mi, R.H. Miller, X. Lee, M.L. Scott, S. Shulag-Morskaya, Z. Shao, and et al. LINGO-1 negatively regulates myelination by oligodendrocytes Nat. Neurosci. 8 2005 745 751
17. Y. Gao, B. Wang, Z. Xiao, B. Chen, J. Han, X. Wang, and et al. Nogo-66 regulates nanog expression through stat3 pathway in murine embryonic stem cells Stem Cells Dev. 19 2010 53 60
18. C. Loov, M. Fernqvist, A. Walmsley, N. Marklund, and A. Erlandsson Neutralization of LINGO-1 during in vitro differentiation of neural stem cells results in proliferation of immature neurons PLoS One 7 2012 e29771
19. X. Li, H. Su, Q.L. Fu, J. Guo, D.H. Lee, K.F. So, and et al. Soluble NgR fusion protein modulates the proliferation of neural progenitor cells via the Notch pathway Neurochem. Res. 36 2011 2363 2372
20. C. Mathis, A. Schroter, M. Thallmair, and M.E. Schwab Nogo-A regulates neural precursor migration in the embryonic mouse cortex Cereb. Cortex 20 2010 2380 2390
21. A. Mingorance-Le Meur, B. Zheng, E. Soriano, and J.A. del Rio Involvement of the myelin-associated inhibitor Nogo-A in early cortical development and neuronal maturation Cereb. Cortex 17 2007 2375 2386
22. C. Rolando, R. Parolisi, E. Boda, M.E. Schwab, F. Rossi, and A. Buffo Distinct roles of Nogo-A and Nogo receptor 1 in the homeostatic regulation of adult neural stem cell function and neuroblast migration J. Neurosci. 32 2012 17788 17799
23. M. Pool, M. Niino, I. Rambaldi, K. Robson, A. Bar-Or, and A.E. Fournier Myelin regulates immune cell adhesion and motility Exp. Neurol. 217 2009 371 377
24. L.M. Craveiro, D. Hakkoum, O. Weinmann, L. Montani, L. Stoppini, and M.E. Schwab Neutralization of the membrane protein Nogo-A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures Eur. J. Neurosci. 28 2008 1808 1824
25. C.L. McDonald, K. Steinbach, F. Kern, R. Schweigreiter, R. Martin, C.E. Bandtlow, and et al. Nogo receptor is involved in the adhesion of dendritic cells to myelin J. Neuroinflammation 8 2011 113
26. E.J. Fry, C. Ho, and S. David A role for Nogo receptor in macrophage clearance from injured peripheral nerve Neuron 53 2007 649 662
27. J. Yan, X. Zhou, J.J. Guo, L. Mao, Y.J. Wang, J. Sun, and et al. Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro J. Neurochem. 120 2012 721 731
28. L. Acevedo, J. Yu, H. Erdjument-Bromage, R.Q. Miao, J.E. Kim, D. Fulton, and et al. A new role for Nogo as a regulator of vascular remodeling Nat. Med. 10 2004 382 388
29. T. Walchli, V. Pernet, O. Weinmann, J.Y. Shiu, A. Guzik-Kornacka, G. Decrey, and et al. Nogo-A is a negative regulator of CNS angiogenesis Proc. Natl. Acad. Sci. U. S. A. 110 2013 E1943 E1952
30. H.D. Vanguilder, G.V. Bixler, W.E. Sonntag, and W.M. Freeman Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory J. Neurochem. 121 2012 77 98
31. E.M. Aloy, O. Weinmann, C. Pot, H. Kasper, D.A. Dodd, T. Rulicke, and et al. Synaptic destabilization by neuronal Nogo-A Brain Cell Biol. 35 2006 137 156
32. A. Zemmar, O. Weinmann, Y. Kellner, X. Yu, R. Vicente, M. Gullo, and et al. Neutralization of Nogo-A enhances synaptic plasticity in the rodent motor cortex and improves motor learning in vivo J. Neurosci. 34 2014 8685 8698
33. Z.P. Wills, C. Mandel-Brehm, A.R. Mardinly, A.E. McCord, R.J. Giger, and M.E. Greenberg The nogo receptor family restricts synapse number in the developing hippocampus Neuron 73 2012 466 481
34. F.V. Akbik, S.M. Bhagat, P.R. Patel, W.B. Cafferty, and S.M. Strittmatter Anatomical plasticity of adult brain is titrated by Nogo receptor 1 Neuron 77 2013 859 866
35. A. Delekate, M. Zagrebelsky, S. Kramer, M.E. Schwab, and M. Korte NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale Proc. Natl. Acad. Sci. U. S. A. 108 2011 2569 2574
36. B. Tews, K. Schonig, M.E. Arzt, S. Clementi, M.S. Rioult-Pedotti, A. Zemmar, and et al. Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function Proc. Natl. Acad. Sci. U. S. A. 110 2013 6583 6588
37. H. Lee, S.J. Raiker, K. Venkatesh, R. Geary, L.A. Robak, Y. Zhang, and et al. Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength J. Neurosci. 28 2008 2753 2765
38. S.J. Raiker, H. Lee, K.T. Baldwin, Y. Duan, P. Shrager, and R.J. Giger Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity J. Neurosci. 30 2010 12432 12445
39. A. Kempf, B. Tews, M.E. Arzt, O. Weinmann, F.J. Obermair, V. Pernet, and et al. The sphingolipid receptor S1PR2 is a receptor for Nogo-A repressing synaptic plasticity PLoS Biol. 12 2014 e1001763
40. A. Karlen, T.E. Karlsson, A. Mattsson, K. Lundstromer, S. Codeluppi, T.M. Pham, and et al. Nogo receptor 1 regulates formation of lasting memories Proc. Natl. Acad. Sci. U. S. A. 106 2009 20476 20481
41. T. Petrasek, I. Prokopova, M. Sladek, K. Weissova, I. Vojtechova, S. Bahnik, and et al. Nogo-A-deficient transgenic rats show deficits in higher cognitive functions, decreased anxiety, and altered circadian activity patterns Front. Behav. Neurosci. 8 2014 90
42. S. Budel, T. Padukkavidana, B.P. Liu, Z. Feng, F. Hu, S. Johnson, and et al. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth J. Neurosci. 28 2008 13161 13172
43. S. Vaynman, and F. Gomez-Pinilla License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins Neurorehabil. Neural Repair 19 2005 283 295
44. G. Chytrova, Z. Ying, and F. Gomez-Pinilla Exercise normalizes levels of MAG and Nogo-A growth inhibitors after brain trauma Eur. J. Neurosci. 27 1 2008 1 11
45. M. Sepe, L. Lignitto, M. Porpora, R. Delle Donne, L. Rinaldi, G. Belgianni, and et al. Proteolytic control of neurite outgrowth inhibitor NOGO-A by the cAMP/PKA pathway Proc. Natl. Acad. Sci. U. S. A. 111 2014 15729 15734
46. X. Lee, Z. Yang, Z. Shao, S.S. Rosenberg, M. Levesque, R.B. Pepinsky, and et al. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination J. Neurosci. 27 2007 220 225
47. H. Inoue, L. Lin, X. Lee, Z. Shao, S. Mendes, P. Snodgrass-Belt, and et al. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models Proc. Natl. Acad. Sci. U. S. A. 104 2007 14430 14435
48. J. Liu, P. Speder, and A.H. Brand Control of brain development and homeostasis by local and systemic insulin signalling Diab. Obes. Metab. 16 Suppl. 1 2014 16 20
49. A. Caelers, A. Monge, J. Michael, M.E. Schwab, and D. Bodmer Nogo in the mammalian cochlea Otol. Neurotol. 30 2009 668 675
50. X. Liu, Z. Zuo, W. Liu, Z. Wang, Y. Hou, Y. Fu, and et al. Upregulation of Nogo receptor expression induces apoptosis of retinal ganglion cells in diabetic rats Neural Regen. Res. 9 2014 815 820
51. V. Pernet, S. Joly, D. Dalkara, O. Schwarz, F. Christ, D. Schaffer, and et al. Neuronal Nogo-A upregulation does not contribute to ER stress-associated apoptosis but participates in the regenerative response in the axotomized adult retina Cell Death Differ. 19 2012 1096 1108
52. Q.L. Fu, B. Hu, W. Wu, R.B. Pepinsky, S. Mi, and K.F. So Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection Invest. Ophthalmol. Vis. Sci. 49 2008 975 985
53. J.B. Park, G. Yiu, S. Kaneko, J. Wang, J. Chang, X.L. He, and et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors Neuron 45 2005 345 351
54. J. Wang, C.K. Chan, J.S. Taylor, and S.O. Chan Localization of Nogo and its receptor in the optic pathway of mouse embryos J. Neurosci. Res. 86 2008 1721 1733
55. A. Guzik-Kornacka, A. van der Bourg, F. Vajda, S. Joly, F. Christ, M.E. Schwab, and et al. Nogo-A deletion increases the plasticity of the optokinetic response and changes retinal projection organization in the adult mouse visual system Brain Struct. Funct. 2014 Pubmed (PMID:25284126)
56. C.E. Stephany, L.L. Chan, S.N. Parivash, H.M. Dorton, M. Piechowicz, S. Qiu, and et al. Plasticity of binocularity and visual acuity are differentially limited by nogo receptor J. Neurosci. 34 2014 11631 11640
57. Y. Luo, X. Wu, S. Liu, and K. Li Reactivation of visual cortical plasticity by NEP 1-40 from early monocular deprivation in adult rats Neurosci. Lett. 494 2011 196 201
58. J. Syken, T. Grandpre, P.O. Kanold, and C.J. Shatz PirB restricts ocular-dominance plasticity in visual cortex Science 313 2006 1795 1800
59. A. Logan, Z. Ahmed, A. Baird, A.M. Gonzalez, and M. Berry Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury Brain 129 2006 490 502
60. L. Schnell, and M.E. Schwab Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors Nature 343 1990 269 272
61. T. GrandPre, S. Li, and S.M. Strittmatter Nogo-66 receptor antagonist peptide promotes axonal regeneration Nature 417 2002 547 551
62. P. Freund, E. Schmidlin, T. Wannier, J. Bloch, A. Mir, M.E. Schwab, and et al. Anti-Nogo-A antibody treatment promotes recovery of manual dexterity after unilateral cervical lesion in adult primates - re-examination and extension of behavioral data Eur. J. Neurosci. 29 2009 983 996
63. A. Schmandke, A. Schmandke, and M.E. Schwab Nogo-A: multiple roles in CNS development, maintenance, and disease Neuroscientist 20 2014 372 386
64. B. Zorner, and M.E. Schwab Anti-Nogo on the go: from animal models to a clinical trial Ann. N. Y. Acad. Sci. 1198 Suppl. 1 2010 E22 E34
65. F. Wang, S. Xing, M. He, Q. Hou, S. Chen, X. Zou, and et al. Nogo-A is associated with secondary degeneration of substantia nigra in hypertensive rats with focal cortical infarction Brain Res. 1469 2012 153 163
66. J.L. Cheatwood, A.J. Emerick, M.E. Schwab, and G.L. Kartje Nogo-A expression after focal ischemic stroke in the adult rat Stroke 39 2008 2091 2098
67. A. Eslamboli, R.I. Grundy, and E.A. Irving Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys Neurosci. Lett. 408 2006 89 93
68. T. Wang, J. Wang, C. Yin, R. Liu, J.H. Zhang, and X. Qin Down-regulation of Nogo receptor promotes functional recovery by enhancing axonal connectivity after experimental stroke in rats Brain Res. 1360 2010 147 158
69. J. Ramos-Cejudo, M. Gutierrez-Fernandez, B. Rodriguez-Frutos, M. Exposito Alcaide, F. Sanchez-Cabo, A. Dopazo, and et al. Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis PLoS One 7 2012 e52121
70. S.Y. Tsai, C.M. Papadopoulos, M.E. Schwab, and G.L. Kartje Delayed anti-Nogo-A therapy improves function after chronic stroke in adult rats Stroke 42 2011 186 190
71. E. Kilic, A. ElAli, U. Kilic, Z. Guo, M. Ugur, U. Uslu, and et al. Role of Nogo-A in neuronal survival in the reperfused ischemic brain J. Cereb. Blood Flow Metab. 30 2010 969 984
72. S. Mi, B. Hu, K. Hahm, Y. Luo, E.S. Kam Hui, Q. Yuan, and et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis Nat. Med. 13 2007 1228 1233
73. J.Y. Lee, and S. Petratos Multiple sclerosis: does Nogo play a role? Neuroscientist 19 2013 394 408
74. J. Satoh, H. Tabunoki, T. Yamamura, K. Arima, and H. Konno TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions Neuropathol. Appl. Neurobiol. 33 2007 99 107
75. Y. Yang, Y. Liu, P. Wei, H. Peng, R. Winger, R.Z. Hussain, and et al. Silencing Nogo-A promotes functional recovery in demyelinating disease Ann. Neurol. 67 2010 498 507
76. R.B. Pepinsky, J.W. Arndt, C. Quan, Y. Gao, O. Quintero-Monzon, X. Lee, and et al. Structure of the LINGO-1-anti-LINGO-1 Li81 antibody complex provides insights into the biology of LINGO-1 and the mechanism of action of the antibody therapy J. Pharmacol. Exp. Ther. 350 2014 110 123
77. A. Jurewicz, M. Matysiak, C.S. Raine, and K. Selmaj Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis Neurology 68 2007 283 287
78. M. Reindl, S. Khantane, R. Ehling, K. Schanda, A. Lutterotti, C. Brinkhoff, and et al. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders J. Neuroimmunol. 145 2003 139 147
79. S.A. Litwak, N.L. Payne, N. Campanale, E. Ozturk, J.Y. Lee, S. Petratos, and et al. Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis PLoS One 8 2013 e82101
80. T. Karnezis, W. Mandemakers, J.L. McQualter, B. Zheng, P.P. Ho, K.A. Jordan, and et al. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination Nat. Neurosci. 7 2004 736 744
81. K. Steinbach, C.L. McDonald, M. Reindl, R. Schweigreiter, C. Bandtlow, and R. Martin Nogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitis PLoS One 6 2011 e26341
82. S. Petratos, E. Ozturk, M.F. Azari, R. Kenny, J.Y. Lee, K.A. Magee, and et al. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation Brain 135 2012 1794 1818
83. A. Berges, J. Bullman, S. Bates, D. Krull, N. Williams, and C. Chen Ozanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsies PloS One 10 2015 e0117355
84. L. Dupuis, J.L. Gonzalez de Aguilar, F. di Scala, F. Rene, M. de Tapia, P.F. Pradat, and et al. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis Neurobiol. Dis. 10 2002 358 365
85. Y.S. Yang, N.Y. Harel, and S.M. Strittmatter Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis J. Neurosci. 29 2009 13850 13859
86. N. Jokic, J.L. Gonzalez de Aguilar, L. Dimou, S. Lin, A. Fergani, M.A. Ruegg, and et al. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model EMBO Rep. 7 2006 1162 1167
87. N.Y. Harel, M.E. Cudkowicz, R.H. Brown, and S.M. Strittmatter Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients Biomarkers 14 2009 414 417
88. V. Meininger, P.F. Pradat, A. Corse, S. Al-Sarraj, B. Rix Brooks, J.B. Caress, and et al. Safety, pharmacokinetic, and functional effects of the nogo-A monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial PLoS One 9 2014 e97803
89. J.H. Park, and S.M. Strittmatter Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice Curr. Alzheimer Res. 4 2007 568 570
90. H.Y. Zhu, H.F. Guo, H.L. Hou, Y.J. Liu, S.L. Sheng, and J.N. Zhou Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease Hum. Pathol. 38 2007 426 434
91. J.H. Park, G.A. Widi, D.A. Gimbel, N.Y. Harel, D.H. Lee, and S.M. Strittmatter Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice J. Neurosci. 26 2006 13279 13286
92. E. Masliah, F. Xie, S. Dayan, E. Rockenstein, M. Mante, A. Adame, and et al. Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice Neuroscience 169 2010 488 494
93. F. Simunovic, M. Yi, Y. Wang, L. Macey, L.T. Brown, A.M. Krichevsky, and et al. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology Brain 132 2009 1795 1809
94. T.G. Lesnick, S. Papapetropoulos, D.C. Mash, J. Ffrench-Mullen, L. Shehadeh, M. de Andrade, and et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease PLoS Genet. 3 2007 e98
95. S. Klebe, S. Thier, D. Lorenz, M. Nothnagel, S. Schreiber, C. Klein, and et al. LINGO1 is not associated with Parkinson's disease in German patients Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 153B 2010 1173 1178
96. F.C. Su, C.M. Chen, Y.C. Chen, and Y.R. Wu LINGO-2 polymorphism and the risk of Parkinson's disease in Taiwan Parkinsonism Relat. Disord. 18 2012 609 611
97. Y.R. Wu, E.K. Tan, C.M. Chen, P.M. Kumar, G.J. Lee-Chen, and S.T. Chen Genetic analysis of leucine-rich repeat (LRR) and immunoglobulin (Ig) domain-containing, Nogo receptor-interacting protein-1 (LINGO1) in two independent Chinese Parkinson's disease populations Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 156B 2011 99 103
98. S. Seiler, D. Pollini, S. Di Santo, and H.R. Widmer Antagonizing Nogo-receptor 1 promotes the number of cultured dopaminergic neurons and elongates their neurites Neuroreport 24 2013 1047 1052
99. T. Hasegawa, K. Ohno, M. Sano, T. Omura, K. Omura, A. Nagano, and et al. The differential expression patterns of messenger RNAs encoding Nogo-A and Nogo-receptor in the rat central nervous system Brain Res. Mol. Brain Res. 133 2005 119 130
100. Z. Kurowska, P. Brundin, M.E. Schwab, and J.Y. Li Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro Neuroscience 256 2014 456 466
101. K. Schawkat, S. Di Santo, S. Seiler, A.D. Ducray, and H.R. Widmer Loss of Nogo-A-expressing neurons in a rat model of Parkinson's disease Neuroscience 288 2015 59 72
102. R. Willi, E.M. Aloy, B.K. Yee, J. Feldon, and M.E. Schwab Behavioral characterization of mice lacking the neurite outgrowth inhibitor Nogo-A Genes Brain Behav. 8 2009 181 192
103. F.Y. Teng, and B.L. Tang Nogo/RTN4 isoforms and RTN3 expression protect SH-SY5Y cells against multiple death insults Mol. Cell. Biochem. 384 2013 7 19
104. Q.L. Fu, B. Hu, X. Li, Z. Shao, J.B. Shi, W. Wu, and et al. LINGO-1 negatively regulates TrkB phosphorylation after ocular hypertension Eur. J. Neurosci. 31 2010 1091 1097
105. X.X. Liao, D. Chen, J. Shi, Y.Q. Sun, S.J. Sun, K.F. So, and et al. The expression patterns of Nogo-A, myelin associated glycoprotein and oligodendrocyte myelin glycoprotein in the retina after ocular hypertension: the expression of myelin proteins in the retina in glaucoma Neurochem. Res. 36 2011 1955 1961
106. T.Y. Jung, S. Jung, K.H. Lee, V.T. Cao, S.G. Jin, K.S. Moon, and et al. Nogo-A expression in oligodendroglial tumors Neuropathology 31 2011 11 19
107. T. Kuhlmann, A. Gutenberg, H.J. Schulten, W. Paulus, V. Rohde, and W. Bruck Nogo-A expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas? Am. J. Surg. Pathol. 32 2008 1444 1453
108. H. Liao, T. Duka, F.Y. Teng, L. Sun, W.Y. Bu, S. Ahmed, and et al. Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells J. Neurochem. 90 2004 1156 1162
109. N. Xiong, J. Shen, S. Li, J. Li, and H. Zhao Expression of Nogo-66 receptor in human astrocytoma is correlated with tumor malignancy Mol. Biol. Rep. 39 2012 2625 2632
110. S. VanGuilder, H.D. tarkey, W.E. Sonntag, and W.M. Freeman Increased hippocampal NgR1 signaling machinery in aged rats with deficits of spatial cognition Eur. J. Neurosci. 37 2013 1643 1658
111. M. Zagrebelsky, and M. Korte Maintaining stable memory engrams: new roles for Nogo-A in the CNS Neuroscience 283 2014 17 25
112. H. Al Halabiah, A.L. Delezoide, A. Cardona, J.M. Moalic, and M. Simonneau Expression pattern of NOGO and NgR genes during human development Gene Expr. Patterns 5 2005 561 568
113. J. Haybaeck, I.C. Llenos, R.J. Dulay, K. Bettermann, C.L. Miller, T. Walchli, and et al. Expression of nogo-A is decreased with increasing gestational age in the human fetal brain Dev. Neurosci. 34 2012 402 416
114. A. Trifunovski, A. Josephson, P.C. Bickford, L. Olson, and S. Brene Selective decline of Nogo mRNA in the aging brain Neuroreport 17 2006 913 916
115. H. Liu, C.E. Ng, and B.L. Tang Nogo-A expression in mouse central nervous system neurons Neurosci. Lett. 328 2002 257 260
116. E. Nyatia, and D.M. Lang Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells Res.Vet. Sci. 83 2007 287 301
117. D. Hunt, R.S. Coffin, R.K. Prinjha, G. Campbell, and P.N. Anderson Nogo-A expression in the intact and injured nervous system Mol. Cell. Neurosci. 24 2003 1083 1102
118. M. Richard, N. Giannetti, D. Saucier, J. Sacquet, F. Jourdan, and V. Pellier-Monnin Neuronal expression of Nogo-A mRNA and protein during neurite outgrowth in the developing rat olfactory system Eur. J. Neurosci. 22 2005 2145 2158
119. A. Pinzon-Olejua, C. Welte, H. Abdesselem, E. Malaga-Trillo, and C.A. Stuermer Essential roles of zebrafish rtn4/Nogo paralogues in embryonic development Neural Dev. 9 2014 8
120. S.P. Hui, J.R. Monaghan, S.R. Voss, and S. Ghosh Expression pattern of Nogo-A, MAG, and NgR in regenerating urodele spinal cord Dev. Dyn. 242 2013 847 860
121. M. Klinger, H. Diekmann, D. Heinz, C. Hirsch, S. Hannbeck von Hanwehr, B. Petrausch, and et al. Identification of two NOGO/RTN4 genes and analysis of Nogo-A expression in Xenopus laevis Mol. Cell. Neurosci. 25 2004 205 216
122. D.A. Dodd, B. Niederoest, S. Bloechlinger, L. Dupuis, J.P. Loeffler, and M.E. Schwab Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types J. Biol. Chem. 280 2005 12494 12502
123. F. Wang, Z. Liang, Q. Hou, S. Xing, L. Ling, M. He, and et al. Nogo-A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal cortical infarction Neurosci. Lett. 417 2007 255 260
124. C.E. Bandtlow, M. Dlaska, S. Pirker, T. Czech, C. Baumgartner, and G. Sperk Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy Eur. J. Neurosci. 20 2004 195 206
125. G. Novak, D. Kim, P. Seeman, and T. Tallerico Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert Brain Res. Mol. Brain Res. 107 2002 183 189
126. J. Satoh, H. Onoue, K. Arima, and T. Yamamura Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis J. Neuropathol. Exp. Neurol. 64 2005 129 138
127. P. Theotokis, A. Lourbopoulos, O. Touloumi, R. Lagoudaki, E. Kofidou, E. Nousiopoulou, and et al. Time course and spatial profile of Nogo-A expression in experimental autoimmune encephalomyelitis in C57BL/6 mice J. Neuropathol. Exp. Neurol. 71 2012 907 920
128. H. Onoue, J.I. Satoh, M. Ogawa, H. Tabunoki, and T. Yamamura Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls Acta Neurol. Scand. 115 2007 153 160
129. N. Jokic, J.L. Gonzalez de Aguilar, P.F. Pradat, L. Dupuis, A. Echaniz-Laguna, A. Muller, and et al. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity Ann. Neurol. 57 2005 553 556
130. G. Marucci, E. Di Oto, A. Farnedi, R. Panzacchi, C. Ligorio, and M.P. Foschini Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion Hum. Pathol. 43 2012 374 380